史庆丰,高晓东,胡必杰

• 1:复旦大学附属中山医院感染管理科
• 2:复旦大学附属中山医院感染病科

摘要(Abstract)：

新型冠状病毒疫情目前已在全球大流行，随着新型冠状病毒(Severe acute respiratory syndrome coronavirus 2,SARS-CoV-2)不断进化和变异，相继出现多种关切变异株。Delta新冠变异株(原称B.1.617.2)具有传播力强、感染潜伏期短、致病性强、发病进程快等特点，逐渐成为印度乃至全球主要的流行毒株，并导致多个国家和地区的疫情反弹。本文就Delta新冠变异株现阶段流行特点及核心防控措施进行综述。

关键词(KeyWords)： 新型冠状病毒;Delta变异株;疫苗;控制

Abstract:

Keywords:

基金项目(Foundation): 上海市科委-阻止新冠肺炎轻症向重症转化的综合救治方案研究(20411950500)上海市科委-上海市新型冠状病毒感染的肺炎流行病学研究(20411950104)

作者(Author): 史庆丰,高晓东,胡必杰

参考文献(References)：

• [1] Klavinskis LS,Liu MA,Lu S.A timely update of global COVID-19 vaccine development[J].Emerg Microbes Infect,2020,9(1):2379-2380.
• [2] Galloway S E,Paul P,MacCannell D R,et al.Emergence of SARS-CoV-2 B.1.1.7 lineage -United States,December 29,2020-January 12,2021[J].MMWR Morb Mortal Wkly Rep,2021,70(3):95-99.
• [3] Chen J,Wang R,Wang M,et al.Mutations strengthened SARS-CoV-2 infectivity[J].J Mol Biol,2020,432(19):5212-5226.
• [4] Bal A,Destras G,Gaymard A,et al.Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69-V70,France,August to December 2020[J].Euro Surveill,2021,26(3) :2100008.
• [5] Feder KA,Pearlowitz M,Goode A,et al.Linked clusters of SARS-CoV-2 variant B.1.351 - Maryland,January-February 2021[J].MMWR Morb Mortal Wkly Rep,2021,70(17):627-631.
• [6] Loconsole D,Centrone F,Morcavallo C,et al.Rapid spread of the SARS-CoV-2 variant of concern 202012/01 in Southern Italy (December 2020-March 2021)[J].Int J Environ Res Public Health,2021,18(9):4766.
• [7] Choudhary J,Dheeman S,Sharma V,et al.Insights of severe acute respiratory syndrome coronavirus (SARS-CoV-2) pandemic:a current review[J].Biol Proced Online,2021,23(1):5.
• [8] Xiaolu T,Changcheng W,Xiang Li,et al.On the origin and continuing evolution of SARS-CoV-2[J].National Science Review,2020,7(6):1012-1023.
• [9] Rambaut A,Holmes EC,O′Toole A,et al.A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology[J].Nat Microbiol,2020,5(11):1403-1407.
• [10] Khan A,Zia T,Suleman M,et al Higher infectivity of the SARS-CoV-2 new variants is associated with K417N/T,E484K,and N501Y mutants:An insight from structural data[J].J Cell Physiol,2021.doi:10.1002/jcp.30367.
• [11] 世界卫生组织.防止污名化!世卫组织宣布采用希腊字母命名变异病毒[EB/OL].(2021-06-01)[2021-06-28].https://www.sohu.com/a/469870217_121107000.
• [12] Deng X,Garcia-Knight MA,Khalid MM,et al.Transmission,infectivity,and neutralization of a spike L452R SARS-CoV-2 variant[J].Cell,2021,184(13):3426-3437.
• [13] Motozono C,Toyoda M,Zahradnik J,et al.SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity[J].Cell Host Microbe,2021,S1931-3128(21)00284-5.
• [14] Khan A,Wei DQ,Kousar K,et al.Preliminary Structural Data Revealed that the SARS-CoV-2 B.1.617 Variant′s RBD binds to ACE2 receptor stronger than the Wild Type to Enhance the Infectivity[J].Chembiochem,2021.doi:10.1002/cbic.202100191.
• [15] Kemp SA,Collier DA,Datir R,et al.Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation[J].medRxiv,2020.12.05.20241927.doi:10.1101/2020.12.05.20241927.
• [16] Glende J,Schwegmann-Wessels C,Al-Falah M,et al.Importance of cholesterol-rich membrane microdomains in the interaction of the S protein of SARS-coronavirus with the cellular receptor angiotensin-converting enzyme 2[J].Virology,2008,381(2):215-221.
• [17] Di Giacomo S,Mercatelli D,Rakhimov A,et al.Preliminary report on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Spike mutation T478K[J].J Med Virol,2021.doi:10.1002/jmv.27062.
• [18] Mercatelli D,Giorgi FM.Geographic and genomic distribution of SARS-CoV-2 mutations[J].Front Microbiol,2020,11:1800.
• [19] Wang Y,Zhang L,Li Q,et al.Infectivity and antigenicity of SARS-CoV-2 B.1.617 variants[J].Preprint.doi:10.21203/rs.3.rs-596463/v1.
• [20] Hacisuleyman E,Hale C,Saito Y,et al.Vaccine breakthrough infections with SARS-CoV-2 variants[J].N Engl J Med,2021,384(23):2212-2218.
• [21] McEwen AE,Cohen S,Bryson-Cahn C,et al.Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State[J].Clin Infect Dis,2021.doi:10.1093/cid/ciab581.
• [22] Wall EC,Wu M,Harvey R,et al Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination[J].Lancet,2021,397(10292):2331-2333.
• [23] Liu J,Liu Y,Xia H,et al.BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants[J].Nature,2021.doi:10.1038/s41586-021-03693-y.
• [24] Saito A,Nasser H,Uriu K,et al.SARS-CoV-2 spike P681R mutation enhances and accelerates viral fusion[J].bioRxiv,2021.doi:10.1101/2021.06.17.448820
• [25] 英国感染“德尔塔毒株”病例占一周确诊病例总数99%[EB/OL].(2021-06-18)[2021-06-28].https://baijiahao.baidu.com/s?id=1702906094530162972&wfr=spider&for=pc
• [26] 欧洲疾控中心：德尔塔毒株将在8月成为欧洲流行的主要毒株[EB/OL].(2021-06-24)[2021-06-28].https://baijiahao.baidu.com/s?id=1703428363849845847&wfr=spider&for=pc
• [27] 美研究：“德尔塔”变异株2-3周内或成为美主流毒株[EB/OL].(2021-06-24)[2021-06-28].https://baijiahao.baidu.com/s?id=1703354803493211923&wfr=spider&for=pc
• [28] 德尔塔变异株全球传播，新冠疫情在以色列重新暴发[EB/OL].(2021-06-24)[2021-06-28].https://www.163.com/dy/article/GD9TP1UU0514AJO3.html.
• [29] Iacobucci G.Covid-19:Are high rates of B.1.617.2 linked to vaccine hesitancy?[J].BMJ,2021,373:n1345.
• [30] 高度警惕!钟南山最新研判来了[EB/OL].(2021-06-26)[2021-06-28].http://k.sina.com.cn/article_1668589317_6374a70501900uwy7.html.
• [31] Sanche S,Lin Y T,Xu C,et al.High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2[J].Emerg Infect Dis,2020,26(7):1470-1477.
• [32] D′Arienzo M,Coniglio A.Assessment of the SARS-CoV-2 basic reproduction number,R 0,based on the early phase of COVID-19 outbreak in Italy[J].Biosaf Health,2020,2(2):57-59.
• [33] Najafimehr H,Mohamed A K,Safari S,et al.Estimation of basic reproduction number for COVID-19 and the reasons for its differences[J].Int J Clin Pract,2020,74(8):e13518.
• [34] Zhou T,Liu Q,Yang Z,et al.Preliminary prediction of the basic reproduction number of the Wuhan novel coronavirus 2019-nCoV[J].J Evid Based Med,2020,13(1):3-7.
• [35] 14秒就感染?接触画面曝光!10天可传五六代![EB/OL].(2021-06-23)[2021-06-28].https://baijiahao.baidu.com/s?id=1703331399868501379&wfr=spider&for=pc
• [36] Delta变异毒株蔓延全球，曾光：大敌当前，这三大群体应率先打加强针[EB/OL].(2021-06-22)[2021-06-28].https://baijiahao.baidu.com/s?id=1703258226500383956&wfr=spider&for=pc
• [37] Dagan N,Barda N,Kepten E,et al.BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting[J].N Engl J Med,2021,384(15):1412-1423.
• [38] Wall EC,Wu M,Harvey R,et al.Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination[J].Lancet,2021,397(10292):2331-2333.
• [39] Sheikh A,McMenamin J,Taylor B,et al.SARS-CoV-2 Delta VOC in Scotland:demographics,risk of hospital admission,and vaccine effectiveness[J].Lancet,2021,397(10293):2461-2462.
• [40] WHO公布科兴新冠疫苗评估报告：效力50%-84%,对老年人有效[EB/OL].(2021-05-04)[2021-06-28].https://baijiahao.baidu.com/s?id=1698822181449017712&wfr=spider&for=pc
• [41] 钟南山院士：国产疫苗对德尔塔毒株有效，大家应该打[EB/OL].(2021-06-27)[2021-06-28].https://www.thepaper.cn/newsDetail_forward_13323339
• [42] Yang J,Marziano V,Deng X,et al.Despite vaccination,China needs non-pharmaceutical interventions to prevent widespread outbreaks of COVID-19 in 2021[J].Nat Hum Behav,2021.doi:10.1038/s41562-021-01155-z.